Literature DB >> 33305809

Extracellular signal-regulated kinase (ERK) pathway control of CD8+ T cell differentiation.

Marcos P Damasio1, Julia M Marchingo1, Laura Spinelli1, Jens L Hukelmann2, Doreen A Cantrell1, Andrew J M Howden1.   

Abstract

The integration of multiple signalling pathways that co-ordinate T cell metabolism and transcriptional reprogramming is required to drive T cell differentiation and proliferation. One key T cell signalling module is mediated by extracellular signal-regulated kinases (ERKs) which are activated in response to antigen receptor engagement. The activity of ERKs is often used to report antigen receptor occupancy but the full details of how ERKs control T cell activation is not understood. Accordingly, we have used mass spectrometry to explore how ERK signalling pathways control antigen receptor driven proteome restructuring in CD8+ T cells to gain insights about the biological processes controlled by ERKs in primary lymphocytes. Quantitative analysis of >8000 proteins identified 900 ERK regulated proteins in activated CD8+ T cells. The data identify both positive and negative regulatory roles for ERKs during T cell activation and reveal that ERK signalling primarily controls the repertoire of transcription factors, cytokines and cytokine receptors expressed by activated T cells. It was striking that a large proportion of the proteome restructuring that is driven by triggering of the T cell antigen receptor is not dependent on ERK activation. However, the selective targets of the ERK signalling module include the critical effector molecules and the cytokines that allow T cell communication with other immune cells to mediate adaptive immune responses.
© 2021 The Author(s).

Entities:  

Keywords:  T-cells; extracellular signal-regulated kinases; proteomics

Year:  2021        PMID: 33305809      PMCID: PMC7813476          DOI: 10.1042/BCJ20200661

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  45 in total

Review 1.  Retinoic Acid and Retinoic Acid Receptors as Pleiotropic Modulators of the Immune System.

Authors:  Alexandre Larange; Hilde Cheroutre
Journal:  Annu Rev Immunol       Date:  2016-05-20       Impact factor: 28.527

Review 2.  AP-1 function and regulation.

Authors:  M Karin; Z g Liu; E Zandi
Journal:  Curr Opin Cell Biol       Date:  1997-04       Impact factor: 8.382

3.  Targeting JAK2 reduces GVHD and xenograft rejection through regulation of T cell differentiation.

Authors:  Brian C Betts; David Bastian; Supinya Iamsawat; Hung Nguyen; Jessica L Heinrichs; Yongxia Wu; Anusara Daenthanasanmak; Anandharaman Veerapathran; Alison O'Mahony; Kelly Walton; Jordan Reff; Pedro Horna; Elizabeth M Sagatys; Marie C Lee; Jack Singer; Ying-Jun Chang; Chen Liu; Joseph Pidala; Claudio Anasetti; Xue-Zhong Yu
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-30       Impact factor: 11.205

4.  Digital signaling and hysteresis characterize ras activation in lymphoid cells.

Authors:  Jayajit Das; Mary Ho; Julie Zikherman; Christopher Govern; Ming Yang; Arthur Weiss; Arup K Chakraborty; Jeroen P Roose
Journal:  Cell       Date:  2009-01-23       Impact factor: 41.582

5.  Interleukin-2 shapes the cytotoxic T cell proteome and immune environment-sensing programs.

Authors:  Christina M Rollings; Linda V Sinclair; Hugh J M Brady; Doreen A Cantrell; Sarah H Ross
Journal:  Sci Signal       Date:  2018-04-17       Impact factor: 8.192

6.  MEK inhibition reprograms CD8+ T lymphocytes into memory stem cells with potent antitumor effects.

Authors:  Vivek Verma; Nazli Jafarzadeh; Shannon Boi; Subhadip Kundu; Zhinuo Jiang; Yiping Fan; Jose Lopez; Rahul Nandre; Peng Zeng; Fatmah Alolaqi; Shamim Ahmad; Pankaj Gaur; Simon T Barry; Viia E Valge-Archer; Paul D Smith; Jacques Banchereau; Mikayel Mkrtichyan; Benjamin Youngblood; Paulo C Rodriguez; Seema Gupta; Samir N Khleif
Journal:  Nat Immunol       Date:  2020-11-23       Impact factor: 25.606

7.  Modeling T cell antigen discrimination based on feedback control of digital ERK responses.

Authors:  Grégoire Altan-Bonnet; Ronald N Germain
Journal:  PLoS Biol       Date:  2005-10-25       Impact factor: 8.029

8.  Antigen receptor control of methionine metabolism in T cells.

Authors:  Linda V Sinclair; Andrew Jm Howden; Alejandro Brenes; Laura Spinelli; Jens L Hukelmann; Andrew N Macintyre; Xiaojing Liu; Sarah Thomson; Peter M Taylor; Jeffrey C Rathmell; Jason W Locasale; Angus I Lamond; Doreen A Cantrell
Journal:  Elife       Date:  2019-03-27       Impact factor: 8.140

9.  Quantitative analysis of how Myc controls T cell proteomes and metabolic pathways during T cell activation.

Authors:  Julia M Marchingo; Linda V Sinclair; Andrew Jm Howden; Doreen A Cantrell
Journal:  Elife       Date:  2020-02-05       Impact factor: 8.140

10.  The cytotoxic T cell proteome and its shaping by the kinase mTOR.

Authors:  Jens L Hukelmann; Karen E Anderson; Linda V Sinclair; Katarzyna M Grzes; Alejandro Brenes Murillo; Phillip T Hawkins; Len R Stephens; Angus I Lamond; Doreen A Cantrell
Journal:  Nat Immunol       Date:  2015-11-09       Impact factor: 25.606

View more
  5 in total

Review 1.  T cell receptor (TCR) signaling in health and disease.

Authors:  Kinjal Shah; Amr Al-Haidari; Jianmin Sun; Julhash U Kazi
Journal:  Signal Transduct Target Ther       Date:  2021-12-13

2.  Proteomics Profiling to Distinguish DOCK8 Deficiency From Atopic Dermatitis.

Authors:  Minnie Jacob; Afshan Masood; Zakiya Shinwari; Mai Abdel Jabbar; Hamoud Al-Mousa; Rand Arnaout; Bandar AlSaud; Majed Dasouki; Ayodele A Alaiya; Anas M Abdel Rahman
Journal:  Front Allergy       Date:  2021-11-29

Review 3.  Protein synthesis, degradation, and energy metabolism in T cell immunity.

Authors:  Julia M Marchingo; Doreen A Cantrell
Journal:  Cell Mol Immunol       Date:  2022-01-04       Impact factor: 22.096

Review 4.  Directing T-Cell Immune Responses for Cancer Vaccination and Immunotherapy.

Authors:  Peter Lawrence Smith; Katarzyna Piadel; Angus George Dalgleish
Journal:  Vaccines (Basel)       Date:  2021-11-25

5.  Phosphoinositide 3-Kinase p110 Delta Differentially Restrains and Directs Naïve Versus Effector CD8+ T Cell Transcriptional Programs.

Authors:  Laura Spinelli; Julia M Marchingo; Aneela Nomura; Marcos P Damasio; Doreen A Cantrell
Journal:  Front Immunol       Date:  2021-06-18       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.